Charles Rivera: Unscripted

Transcripta Bio and Mayo Clinic are combining artificial intelligence and living patient data to map ALS, highlighting how institutions fuel precision medicine.

An N-of-3 pilot study reveals how Krystal Biotech's new intratumoral immunotherapy could replace lifelong surgeries with systemic immune clearance.

Continuity Biosciences aims to eliminate the adherence burden of HIV PrEP with a multi-year nanofluidic implant, backed by the Gates Foundation.

A new card-linked platform in Seattle and Edmonton shifts the burden of charitable giving from consumers to merchants, transforming local community support.

As bird-safe mandates and energy codes reshape American skylines, Turkish industrial giant Sisecam aims to build the sustainable facades of tomorrow.

GreenLight Fund’s latest report shows how a $47.8M investment unlocked $454M, scaling proven social solutions across 15 cities to reach 1.6 million people.

With CFIUS clearance secured, Clear Channel Outdoor's $6.2B acquisition by Mubadala Capital signals a new era for digital out-of-home advertising.

When massive road closures froze Montreal's grid, dynamic bike-share deployment provided a crucial pressure-relief valve for half a million riders.

BookingCentral’s new AI Connector lets rental operators query their fleet and customer data in plain English, bypassing complex dashboards and spreadsheets.

As the U.S. wine market faces historic contractions, Cavit's innovative partnership with Mike's Hot Honey offers a masterclass in institutional adaptation.

Locafy acquires Map Labs in a strategic $3M deal, blending legacy local SEO with AI-driven Answer Engine Optimization to capture the modern search market.

As AI-native disruptors challenge legacy research firms, Euromonitor’s new Passport platform embeds 50 years of trusted data directly into enterprise workflows.

As India transitions from an IT outsourcing hub to the global architect of AI, WeAreDevelopers brings its massive tech conference to Bengaluru to meet the builders of tomorrow.

Equillium's Phase 1 trial of EQ504 in Australia signals a strategic shift in ulcerative colitis care, prioritizing targeted mucosal healing.

Ajinomoto Bio-Pharma Services' latest rebrand signals a vital shift, prioritizing deep technical mastery in complex therapies over the one-stop-shop model.

Nouryon’s first U.S. solar project in Illinois reveals how chemical manufacturers are leveraging on-site renewables to cut emissions and hedge power costs.

C1 Fund takes its mission of accessible venture capital to major investor conferences, riding the momentum of high-profile portfolio milestones and buybacks.

As South Korean retail traders pour billions into U.S. equities, Webull is quietly pivoting from a consumer app to an enterprise tech provider.

Alexis Miestowski and Marissa Wenzler just became the Grass League's first female General Managers, merging digital influence with franchise leadership.

AI fashion platform Daydream integrates deeply with Apple's iOS 27, proving the future of shopping isn't another app—it's an ambient, frictionless service.